Company Filing History:
6 out of 7 
1 out of 12 Years Active: 2021-2025
Title: The Innovative Contributions of Donghoon Seo
Introduction
Donghoon Seo is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibody-drug conjugates. With a total of 6 patents to his name, Seo's work is recognized for its potential impact on therapeutic applications.
Latest Patents
Seo's latest patents include innovative compounds and compositions that utilize substituted benzodiazepines as antibody-drug conjugates. One of his notable patents focuses on antibody-drug conjugates comprising anti-B7-H3 antibodies. This patent details how active agents can be conjugated to an anti-B7-H3 antibody through a linker, which may include units that covalently link these agents to the antibody. The disclosure also covers monoclonal antibodies and their variants that specifically bind to B7-H3, along with methods for their therapeutic, diagnostic, and prophylactic use.
Career Highlights
Throughout his career, Donghoon Seo has worked with various companies, including Intocell, Inc. and Y-Biologics Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.
Collaborations
Seo has collaborated with notable colleagues such as Taekyo Park and Sung Ho Woo. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Donghoon Seo's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a leading inventor. His work on antibody-drug conjugates has the potential to significantly impact therapeutic practices in medicine.